Inventor · disambiguated record
Lv Liao
Also filed as: LIAO LV
14 granted patents·3 pending applications·59 citations·filing 2013–2021
90Inventor score
Top patents by PatentIndex Score
17 records- 0194US10947218B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2020·Granted Mar 16, 2021·6 cites·13 claims
- 0291US10710980B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·8 cites·6 claims
- 0391US9533988B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2015·Granted Jan 3, 2017·13 cites·8 claims
- 0490US9266883B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2014·Granted Feb 23, 2016·16 cites·13 claims
- 0585US8815926B2Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseasesNOVARTIS AG·Filed 2013·Granted Aug 26, 2014·8 cites·25 claims
- 0679US10844055B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2019·Granted Nov 24, 2020·1 cites·15 claims
- 0778US10130629B2Pharmaceutical combinationsNOVARTIS AG·Filed 2016·Granted Nov 20, 2018·3 cites·7 claims
- 0878US9896449B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2016·Granted Feb 20, 2018·2 cites·1 claims
- 0978US9802917B2Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamideBUSCHMANN NICOLE·Filed 2016·Granted Oct 31, 2017·2 cites·15 claims
- 1070US12466808B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 1170US10463653B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2018·Granted Nov 5, 2019·0 cites·4 claims
- 1267US11530213B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·16 claims
- 1361US10266531B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2017·Granted Apr 23, 2019·0 cites·23 claims
- 1456US10507201B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·0 cites·17 claims
- 1552US2014343084A1Imidazopyrrolidinone compoundsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 1646US2018185341A1Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1744US2014205566A1Cyclic nucleuoside derivatives and uses thereofLIAO LV·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →